EX-1 2 v151333_ex1.htm
EXHIBIT 1

AGREEMENT
 
In accordance with Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended, the undersigned hereby agree that this Statement on Schedule 13D relating to the Common Stock, $0.01 par value, of Biocryst Pharmaceuticals, Inc. is being filed with the Securities and Exchange Commission on behalf of each of them.
 
June 1, 2009
 
By:
/s/ Julian C. Baker  
    Julian C. Baker  
       
       
  By: /s/ Felix J. Baker  
    Felix J. Baker